Statin exposure and thrombosis risk in patients with myeloproliferative neoplasms

Authors :: Brigitte Pan-Petesch
Hubert Galinat
Karine Lacut
Jean-Christophe Ianotto
Eric Lippert
Aurélien Delluc
Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO)
Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM)
Université de Brest (UBO)-Université de Brest (UBO)
Centre Régional de Traitement des Hémophiles [CHU Brest]
Centre Hospitalier Régional Universitaire de Brest (CHRU Brest)
Service d'hématologie biologique
Laboratoire d'hématologie
CHU Bordeaux [Bordeaux]
CHRU Brest - Service d'Hématologie (CHU-Brest-Hemato)
Calvez, Ghislaine
Source :: Thrombosis Research, Thrombosis Research, Elsevier, 2018, 167, pp.57-59
Publication Year :: 2018
Publisher :: HAL CCSD, 2018.
Abstract: International audience

Subjects :: Adult
Male
medicine.medical_specialty
Statin
medicine.drug_class
[SDV]Life Sciences [q-bio]
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
Text mining
[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
Internal medicine
Humans
Medicine
In patient
ComputingMilieux_MISCELLANEOUS
Aged
Myeloproliferative Disorders
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology
business.industry
Thrombosis
Hematology
Middle Aged
[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
3. Good health
[SDV] Life Sciences [q-bio]
030220 oncology & carcinogenesis
Female
Hydroxymethylglutaryl-CoA Reductase Inhibitors
business
Thrombotic complication
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

Language :: English
ISSN :: 00493848
Database :: OpenAIRE
Journal :: Thrombosis Research, Thrombosis Research, Elsevier, 2018, 167, pp.57-59
Accession number :: edsair.doi.dedup.....3687409c15822bb113bde4c346831ca2

Tools